



Analyzing events over time is often complicated by incomplete, or censored, observations. Special non-parametric statistical methods were deve-
loped to overcome diffi  culties in summarizing and comparing censored data. Life-table (actuarial) method and Kaplan-Meier method are described 
with an explanation of survival curves. For the didactic purpose authors prepared a workbook based on most widely used Kaplan-Meier method. It 
should help the reader understand how Kaplan-Meier method is conceptualized and how it can be used to obtain statistics and survival curves nee-
ded to completely describe a sample of patients. Log-rank test and hazard ratio are also discussed.
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The time variable, i.e. the length of time until an 
event occurs, is one of many diff erent research 
variables that can be recorded and statistically an-
alyzed. For example, in survival analysis, we are fo-
cused on patient’s survival, which is the main clini-
cal interest, and death is the unwanted event. Any 
other event may also be taken as an endpoint as 
long as it can be described as binary, e.g. 1 if the 
event occurred and 0 if it did not occur (binary set-
ting assumes that no other event is possible). For 
example, we can analyze time to graduation in a 
population of students and report a graduation 
rate at fi ve years or determine a median gradua-
tion time. In biomedicine, there are many possible 
uses of this type of analysis, such as analyzing time 
to recovery after a therapeutic procedure, time to 
reach a predefi ned blood level of a substance, time 
to relapse of disease, time to hospital discharge, 
and many others.
Why do we need special methods to 
analyze survival data?
The main diffi  culty in the analysis of survival data 
is that patients are not enrolled in the study all at 
the same time, but dropwise (the follow-up of 
each patient starts at a diff erent time point). For 
example, we cannot perform surgery on 50 pa-
tients at the same time in order to start observing 
their survival from that moment on. Patients with 
the disease of our interest come over time, one by 
one, not on the day set as the beginning of the 
study. Therefore, patients included in the survival 
analysis are, as a rule, followed up for diff erent 
lengths of time due to their gradual infl ux (1). Pa-
tients enrolled later in the study are followed up 
for a shorter time and usually are still alive at the 
time of data analysis, while others drop out at 
some point during the study and are lost from ob-
servation (lost to follow-up). In either case, we can-
not evaluate what happened to them after the 
time of last visit when they were still alive. Infor-
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mation on such patients remains unknown, i.e. 
censored, but we record their status as if they were 
still alive (by 0). If we analyzed such censored data 
using standard statistical methods, for example, if 
we compared the median time needed to reach 
the endpoint in two groups, we would receive mis-
leading results (2).
If we were to calculate a 5-year survival rate for 50 
patients who underwent a particular treatment, 
we would have to observe each one of these pa-
tients (even the ones who died) for fi ve years and 
then divide the number of survivors by the total 
number of patients (Nsurviving/Ntotal) (3). Such an ap-
proach is usually called a direct method and, in the 
above example, it would take longer than fi ve 
years to calculate the 5-year survival rate. All pa-
tients who were followed up for less than fi ve 
years, whether alive or dead would have to be ex-
cluded from the calculation. This is a disadvantage 
of the direct method as it goes against the rule of 
intention-to-treat analysis. Another disadvantage 
of the direct method of calculation (3) is that we 
cannot calculate the mean survival time before we 
know all survival times (4) (e.g. until all patients 
die). In some cases, it could take decades. In the di-
rect method, some of the censored surviving times 
would be discarded, although they contain valu-
able information about survival up to some point 
in time.
In a typical clinical study, patient follow-up times 
usually do not follow a normal distribution (Figure 
1) and, therefore, follow-up data have to be pre-
sented as median with range and analyzed using 
nonparametric statistical methods.
About censoring
Whenever we analyze censored data, we have to 
ensure that the entry and censoring criteria remain 
the same during the entire enrollment period (5,6). 
In other words, we must strictly defi ne the starting 
point (intended-to-treat or treated patients) and 
the endpoint (death, but also death only from a 
specifi c cause; disease relapse; etc.). We also have 
to recheck data on all patients lost to follow-up. 
The proportion of patients lost to follow-up should 
be the smallest possible, because too many pa-
tients lost from observation can make survival 
analysis unreliable. Removing or recording unfa-
vorable outcomes as lost is not allowed, because it 
alters the results and leads to wrong conclusions.
Actuarial (life-table) method and 
Kaplan-Meier method
Insurance companies are always interested in how 
likely someone is to die/live for some defi ned pe-
riod of time. For that purpose, they have devel-
oped a life-table method to calculate the data in 
certain groups of people. This method is also 
called the actuarial method (actuary – professional 
dealing with fi nancial risks) (1). It divides the obser-
vation period into equal time intervals and calcu-
lates the proportion dying in each one of them. 
Proportion dying in each time interval is set as 
Ndied/Nexposed or Ndied/(Ntotal in interval - Ncencored/2). 
The method assumes that censored observations 
contribute only halfway to the number of patients 
currently at risk (during given time interval), and 
that is called actuarial assumption. Someone who 
lived up to the 8th time interval had to live through 
seven previous time intervals, so their risk of dying 
accumulates. It should be noted that proportions 
of dying and surviving add up to 1 (proportion dy-
ing = 1 – proportion surviving). A cumulative pro-
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FIGURE 1. Survival times usually do not have normal distribu-
tion. The histogram presents a follow-up (months) of 152 pa-
tients from the study (10). The normal distribution was calcu-
lated and is presented by a dashed line (empirical data were not 
compared using one-sample normality test).
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time interval, as it is multiplied with proportion dy-
ing in preceding time intervals, while a cumulative 
proportion surviving is decreasing and represents 
the survival rate up to the time interval. Life-table 
method is useful when death and censored obser-
vations are already organized in time intervals, 
which is rarely the case in biomedical research.
Kaplan-Meier method (product-limit method) 
(1,7,8) uses a similar principle to calculate the cu-
mulative proportion surviving over time, with a 
new time interval starting with each new death. 
Censored observations are placed in correspond-
ing intervals and contribute to the total number of 
subjects (if censored observation happens at the 
same time as death, it is assumed to happen a bit 
after and is placed in the following interval). To cal-
culate proportion dying, the method simply di-
vides the number of deaths in a time interval (al-
ways 1) with the total number of subjects at the 
beginning of the interval. Cumulative proportion 
dying and surviving are calculated in the same 
manner as in actuarial method. The fi rst interval al-
ways ends with the fi rst (earliest) death, does not 
include any death times, and has a surviving pro-
portion of 100%.
Proportions surviving through consecutive inter-
vals may be presented as a survival curve, which 
represents a survival function over time (Figure 2). 
This plot is a step function with gradually falling 
steps if deaths in the following intervals occur. Sur-
vival rate (cumulative proportion surviving) can be 
read from the curve at any time point. Median sur-
vival time is the time point at which 50% of pa-
tients died/survived and can also be read from the 
survival curve (1,2,4,8). The last interval is always 
open and represents the survival rate from the last 
death observed (Kaplan-Meier method) or defi ned 
interval border (actuarial method) to infi nity. The 
analysis of survival data by Kaplan-Meier, actuarial 
or direct method (in the last case, incomplete ob-
servations must be excluded) produces almost the 
same results, but Kaplan-Meier method is usually 
the method of choice as it produces the most ac-
curate information for any given follow-up time. 
When there are no censored data, i.e., none of pa-
tients is lost and all observed patients died, the re-
sults of all three methods are the same (3).
Calculating survival using Excel sheets
For the didactic purposes of this text, we prepared 
a workbook for MS Excel program (ver. 2002, Mi-
crosoft, Redmond, Washington, USA), which is 
freely available as supplementary fi le at http://
www.biochemia-medica.com. It is based on most 
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FIGURE 2. Survival curves from the study (10) created using Ka-
plain-Meier estimation. The survival curve itself (upper), with 
designated censored events (middle), and survival curve with 
the upper and lower 95% confi dence interval curves (lower). 
Time is shown in months.
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commonly used Kaplan-Meier method and in-
tended to help the reader understand how Ka-
plan-Meier method is conceptualized and how it 
may be used to obtain statistics and survival curves 
needed to describe a sample of patients. A reader 
can copy/paste his own recorded data into provid-
ed columns either as a start date, last control date 
and status indicator (1 – dead, 0 – alive), or directly 
as prerecorded follow-up time and status indica-
tor (Figure 3). The program reports the total num-
ber of patients, number of patients reaching the 
endpoint, number of censored observations, and 
median follow-up time with range (from the small-
est to the largest observed time) (Figure 4). The 
median survival time is reported only if it is 
reached. The survival rate can be calculated for 
any point in time by entering the desired time in a 
specifi ed box (entry is preset to 60 months to ob-
tain the usual 5-year survival rate). Survival rates 
are calculated with standard errors and provided 
with 95% confi dence intervals. The survival curve 
and survival curve with 95% confi dence interval 
are plotted (Figure 4).
FIGURE 4. Numerical results of survival data analysis from the 
workbook summarizing the number of patients from the study 
(10), median follow-up time with data range (in months, in this 
example), median survival time, and survival rate at 60 months 
with respective standard error and 95% confi dence interval.
FIGURE 3. Data from the entry page of the workbook. Each 
patient from the study (10) is designated with a serial identity 
number (ID, column A). Survival times were calculated from the 
start date (column B) and the date of last control (column C) for 
each patient (in months, column D) or were entered directly. 
Each patient is designated with a status indicator (column E: 0 – 
censored, 1 – dead).
Comparing two survival curves
A number of factors can impact a survival rate over 
time and cause survival curve to change. We can 
test if some factor signifi cantly changes the surviv-
al by comparing two groups using log-rank test. 
The test assumes no diff erence in dying propor-
tions between two groups and calculates the pro-
portion dying in every time interval (1,5). Then it 
multiplies this number with the current number at 
risk in each group to calculate the expected num-
ber of deaths. After summing up all expected 
deaths, we can compare the expected number of 
deaths with the observed number of deaths (for 
each group independently), usually using χ2-test. 
There are diff erent types of log-rank tests, some 
named after respective authors, that slightly diff er 
in their calculations (Cox-Mantel, Peto, Mantel-
Haenszel, and some others) (8). When test statistic 
is obtained, the P-value is read from the normal or 
χ2-distribution for one degree of freedom (de-
pending on the type of log-rank calculation used). 
The slope of survival curve at some point in time is 
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Analiza nepotpuno praćenih podataka
Sažetak
Analiza događaja tijekom vremena otežana je nepotpunim (cenzoriranim) praćenjem. Posebne, neparametrijske metode razvijene su kako bi se 
skupljeni podaci unatoč tome mogli opisivati i uspoređivati. Opisane su metoda životne tablice (engl. life-table) i Kaplan-Meierova metoda uz 
objašnjenje krivulja preživljenja. Uz ovaj članak pripremljena je i posebna MS Excel radna knjiga, bazirana na češće korištenoj Kaplan-Meierovoj 
metodi, namijenjena učenju i boljem razumijevanju analize preživljenja. Pomoći će čitatelju da samostalno opiše vlastite podatke i dobije krivulje 
preživljenja. Dan je osvrt na log-rank test i omjer rizika (engl. hazard ratio, HR).
Ključne riječi: aktuarijska metoda; analiza preživljenja; cenzorirani podaci; Kaplan-Meierova metoda; log-rank test
termed hazard and represents the rate of dying for 
that follow-up time.
We can use log-rank test only if survival curves do 
not cross each other (the assumption of propor-
tional hazards during the follow-up, i.e. the risk of 
event in group A is consistently greater or lower 
than risk in Group B). If this is true, the proportion 
can be calculated by comparing the expected and 
observed deaths in both groups. It is called hazard 
ratio and allows us to estimate the degree to which 
a tested factor contributes to survival. For exam-
ple, if hazard ratio and lower limit of its 95% confi -
dence interval are higher than 1, we can be 95% 
certain that this factor increases the risk of dying 
by the value of hazard ratio (9). In case survival 
curves cross later during follow up, special type of 
weighted log-rank test (Breslow-Gehan general-
ization of Wilcoxon test) can be used as it gives 
more weight to early observations when calculat-
ing test statistic. However, we can not use hazard 
ratio or make conclusions about diff erence in sur-
vival after point where curves cross each other.
Conclusion
When analyzing the time to the occurrence of an 
event, one has to be wary of falling into statistical 
traps. Special methods have been developed to 
summarize and compare this type of data without 
losing valuable information contained in censored 
observations. Kaplan-Meier method is most wide-
ly used for summarizing data. Variants of log-rank 
test are usually used for comparing two survival 
curves. These methods also provide an estimate of 
how much a tested factor increases the risk of dy-
ing, which is called hazard ratio.
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